TRINITY

What TRINITY does

Trinity Life Sciences is a technology-enabled commercialization partner for the life sciences industry, focused on pharmaceutical, biotech, and medtech clients across the product lifecycle from pipeline planning through launch and brand optimization. The firm combines human domain expertise with an integrated AI platform centered on the proprietary Weave AI data fabric, which unifies primary market research, prescription claims, EMR/EHR, CRM, and field feedback at the individual HCP, patient, and payer level. On this foundation the company offers TrinityEDGE as an umbrella platform housing InsightsEDGE (integrated insights and Digital Twins for HCP, patient, and payer simulation), ForecastEDGE (forecasting), Launch Accelerator (launch planning and execution), MDM (master data management), and Sentiment (performance and sentiment analytics), alongside TGaS Advisors benchmarking and content services such as the Digital Marketing Competency Report and State of Global Market Access white paper.

The company operates a hybrid professional-services-plus-platform business model: revenue is generated through multi-year enterprise consulting engagements, technology subscriptions, and benchmarking/advisory memberships. Go-to-market is enterprise field sales with expert-led demos and direct engagement of commercial, medical, market access, and analytics buyers — there is no reseller or self-service channel. Trinity employs 1,300 professionals across 14 offices on five continents (Waltham HQ plus Cambridge, New York, Princeton, San Francisco, East Norriton, London, Mexico City, Singapore, Tokyo, and four India locations) and claims involvement in 70% of all new drug launches and 350+ enterprise customers. Recent inorganic expansion includes acquisitions of Bell Canyon (2019), CBPartners (2021), D Cube Analytics (2022), and EVERSANA's APACME advisory unit (2025), plus a strategic minority investment from Bain & Company in August 2022. Leadership transitioned in November 2025 with Scott Evangelista appointed CEO and Colin Boatwright appointed as the firm's first CIO in June 2026.

Name

TRINITY

Legal name

Trinity Partners, LLC

Website

https://trinitylifesciences.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Trinity Life Sciences is a technology-enabled commercialization partner for pharmaceutical, biotech, and medtech companies, combining AI-powered platforms (InsightsEDGE, Weave AI, Digital Twins, ForecastEDGE) with consulting services across drug launch, market access, and brand optimization.

Ownership category

akta.pro rank

Product category

Life Sciences Commercialization Services

NAICS

Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416), Software Publishers (513210)

SIC

Services-Engineering, Accounting, Research, Management (8700), Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Life sciences consulting
• Commercialization strategy
• Market access analytics
• Drug launch planning
• Healthcare market research

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Technology-Enabled Consulting Services: Trinity provides comprehensive commercialization solutions including strategic planning, market research, analytics, and technology platforms. Services span from pre-commercial pipeline planning through brand optimization and launch excellence.
2. Technology Platform Subscriptions: SaaS-based platforms including InsightsEDGE, TrinityEDGE, ForecastEDGE, and Launch Accelerator offered as technology solutions to life sciences companies.
3. Benchmarking and Advisory Services: TGaS Advisors division provides benchmarking, advisory, and membership services including Digital Marketing Competency Reports and Best of Benchmark Awards.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Trinity Life Sciences is a technology-enabled commercialization solutions provider serving the pharmaceutical, biotechnology, and medical device industries. The company helps life sciences clients develop, launch, and optimize products through its TrinityEDGE platform, AI-driven insights (InsightsEDGE), forecasting tools (ForecastEDGE), launch planning accelerators, and a comprehensive suite of consulting, market research, market access, and benchmarking services. Its offerings combine proprietary data, advanced analytics, and human expertise to support brand strategy, payer engagement, and field force effectiveness.

Product overview

Trinity is a technology-enabled commercialization solutions provider for the life sciences industry, operating as a platform-plus-modules architecture. The core platform is TrinityEDGE™, which encompasses multiple integrated technology solutions including InsightsEDGE™ (integrated insights platform), ForecastEDGE™ (AI-enabled forecasting, formerly CloudCast™), Launch Accelerator™ (launch planning tool), and MDM (Master Data Management). The InsightsEDGE platform features specialized modules including InsightsEDGE™ | Digital Twins (AI-powered synthetic personas for HCPs, patients, and payers), InsightsEDGE™ Weave (proprietary AI data fabric), and Sentiment (marketing communications insights). Trinity AI represents the company's broader AI solutions portfolio powering generative and agentic AI capabilities. Beyond technology products, Trinity offers comprehensive services organized across strategic planning & forecasting, value/access & pricing, integrated insights, launch planning & execution, customer engagement, and foundational data & AI capabilities. The company also operates TGaS Advisors, a division providing benchmarking and advisory services including annual research reports on digital marketing, learning & development, and market access. Trinity has expanded through acquisitions including D Cube Analytics (2022), Bell Canyon (2019), and EVERSANA's APACME advisory services (2025), and maintains a strategic partnership with Bain & Company (2022).

Differentiator

Problem solved

Functional benefit

Brands

• TGaS Advisors: A division of Trinity providing benchmarking, advisory and membership services for pharmaceutical organizations
• TrinityEDGE
• InsightsEDGE
• ForecastEDGE
• Launch Accelerator

Products and services

• TrinityEDGE Unified AI-powered data fabric and insights platform that integrates Trinity's full suite of commercialization solutions, providing a single technology backbone for life sciences clients across market access, market research, forecasting, and brand strategy engagements.
• InsightsEDGE Integrated insights platform that combines primary market research, secondary data analysis, and AI-enabled intelligence to deliver actionable commercial insights for pharmaceutical and biotech brand teams.
• ForecastEDGE Predictive forecasting and analytics engine that supports commercial demand forecasting, salesforce sizing, and brand performance modeling for life sciences clients.
• Launch Accelerator Launch planning and execution solution providing structured frameworks, analytics, and project management tools to support pharmaceutical and biotech product launches from pre-launch through maturity.
• InsightsEDGE Digital Twins Agentic AI product that creates digital twins of healthcare professionals and patients to simulate behaviors, preferences, and responses, enabling life sciences clients to optimize launch strategies, messaging, and channel investments.
• TGaS Advisors Membership-based benchmarking and advisory network providing pharmaceutical operations and commercial excellence leaders with peer benchmarks, best-practice research, and operational diagnostics.
• HTA Vision Health Technology Assessment (HTA) solution supporting market access and reimbursement strategy for life sciences clients navigating payer and HTA agency evaluations across global markets.
• Sentiment AI-powered sentiment analysis solution that processes unstructured data to surface stakeholder sentiment and emerging signals for life sciences commercial teams.

Quantifiable outcome

• Up to 90% accuracy in predicting revenue outcomes for drug launches
• +5 more outcomes

Named customers13 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature9 records

Partnerships

Two partnerships are on record, tiered core.

• EVERSANA (Acquisition of APACME Advisory Services)coreStrategic or Co-development Partner · 3 November 2025Trinity acquired EVERSANA's advisory services operation in Asia-Pacific and the Middle East to enhance global life sciences services and presence. Acquisition aims to strengthen Trinity's position in the APACME region, supporting growth and client impact. Transaction expands Trinity's global footprint in the APACME region.
• Bain & CompanycoreStrategic or Co-development Partner · 8 August 2022Strategic partnership announced August 8, 2022 including Bain's minority investment in Trinity. Partnership aims to combine expertise in life sciences and digital transformation solutions to better serve clients globally. The collaboration enhances strategic consulting and data analytics capabilities across the industry, following Trinity's recent partnerships and acquisitions to expand offerings.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• IQVIA: IQVIA is the largest life sciences commercialization, analytics, and R&D services company globally. It directly overlaps with Trinity's market research, forecasting, and commercial analytics offerings but operates at much greater scale across the full pharma value chain.
• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering both clinical and commercial services. It overlaps with Trinity in commercial strategy, market access, and deployment services, though with a much larger CRO heritage.
• Parexel International: Parexel is a global CRO with growing commercial and real-world evidence services for life sciences. It competes for the same enterprise pharma budgets Trinity targets, particularly around evidence, market access, and commercialization strategy.
• McKinsey & Company (Pharma Practice): McKinsey's pharma and medical products practice competes with Trinity on strategy, launch, and commercial transformation engagements. As a tier-one consultancy with adjacent QuantumBlack AI capabilities, it pressures Trinity on the high end of the pharma enterprise market.

Direct peers

• ZS Associates: ZS Associates is a management consulting and technology firm focused on pharmaceutical sales, marketing, and AI-driven analytics. It is the closest direct peer to Trinity, with overlapping offerings in field force effectiveness, call planning, and AI-enabled commercial strategy.
• EVERSANA: EVERSANA is a life sciences commercialization services provider spanning market access, patient services, and commercial operations. Trinity's recent acquisition of EVERSANA's APACME advisory business underscores the direct overlap in commercialization advisory work.
• Veeva Systems: Veeva is a leading SaaS provider for life sciences commercial and R&D functions, including CRM, data, and content management. It competes with Trinity's TrinityEDGE platform on the technology layer that pharma commercial teams use day-to-day.
• Charles River Associates: CRA's Life Sciences practice provides commercial strategy, pricing, market access, and HEOR consulting to pharma and biotech. It is a direct peer to Trinity on evidence, value, and access advisory work for mid-to-large life sciences clients.

Emerging players

• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics on healthcare providers, organizations, and markets. It is an emerging SaaS player in the same data-and-insights category Trinity serves with InsightsEDGE and Weave AI.
• Komodo Health: Komodo Health offers a real-world data and analytics platform for healthcare and life sciences, including HCP and patient journey mapping. Its technology-forward approach to commercial intelligence overlaps with Trinity's Digital Twins and InsightsEDGE value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/TrinityLifeSciences
• LinkedInlinkedin.com/company/trinitylifesciences
• Instagraminstagram.com/trinitylifesciences/?hl=en
• Xx.com/trinitylifesci

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TRINITY